DEPDC5
Basic information
Region (hg38): 22:31753867-31908033
Links
Phenotypes
GenCC
Source:
- epilepsy, familial focal, with variable foci 1 (Definitive), mode of inheritance: AD
- epilepsy, familial focal, with variable foci 1 (Definitive), mode of inheritance: AD
- epilepsy, familial focal, with variable foci 1 (Definitive), mode of inheritance: AD
- epilepsy, familial focal, with variable foci 1 (Definitive), mode of inheritance: AD
- autosomal dominant nocturnal frontal lobe epilepsy (Supportive), mode of inheritance: AD
- familial focal epilepsy with variable foci (Supportive), mode of inheritance: AD
- autosomal dominant epilepsy with auditory features (Supportive), mode of inheritance: AD
- epilepsy, familial focal, with variable foci 1 (Strong), mode of inheritance: AD
- Brugada syndrome (Limited), mode of inheritance: AD
- focal epilepsy (Definitive), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Developmental and epileptic encephalopathy 111 | AR | Allergy/Immunology/Infectious; Cardiovascular | Neutropenia and recurrent infections have been described, and awareness may allow early and aggressive treatment of infections; Developmental and epileptic encephalopathy 111 can include cardiovascular anomalies, and awareness may allow early diagnosis and management | Allergy/Immunology/Infectious; Cardiovascular; Craniofacial; Neurologic; Ophthalmologic | 9851433; 10577924; 14510823; 15329069; 22780917; 23542697; 23542701; 24814846; 25623524; 36067010 |
ClinVar
This is a list of variants' phenotypes submitted to
- Familial focal epilepsy with variable foci (163 variants)
- not provided (31 variants)
- Epilepsy, familial focal, with variable foci 1 (28 variants)
- Inborn genetic diseases (10 variants)
- Seizure (4 variants)
- See cases (4 variants)
- Autosomal dominant nocturnal frontal lobe epilepsy (1 variants)
- DEPDC5-related disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DEPDC5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 331 | 12 | 352 | |||
missense | 853 | 17 | 883 | |||
nonsense | 77 | 14 | 91 | |||
start loss | 1 | |||||
frameshift | 95 | 26 | 10 | 131 | ||
inframe indel | 12 | 14 | ||||
splice donor/acceptor (+/-2bp) | 15 | 54 | 72 | |||
splice region | 4 | 61 | 75 | 5 | 145 | |
non coding | 19 | 304 | 100 | 423 | ||
Total | 188 | 100 | 906 | 652 | 121 |
Highest pathogenic variant AF is 0.0000132
Variants in DEPDC5
This is a list of pathogenic ClinVar variants found in the DEPDC5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
22-31754865-G-C | Childhood epilepsy with centrotemporal spikes | Pathogenic (Jan 01, 2017) | ||
22-31754922-A-G | Familial focal epilepsy with variable foci | Uncertain significance (Aug 07, 2023) | ||
22-31754926-G-A | Familial focal epilepsy with variable foci • not specified • Inborn genetic diseases | Conflicting classifications of pathogenicity (Oct 04, 2023) | ||
22-31754926-GAAC-G | Familial focal epilepsy with variable foci | Uncertain significance (Aug 27, 2020) | ||
22-31754935-A-G | Familial focal epilepsy with variable foci | Uncertain significance (Dec 21, 2021) | ||
22-31754939-C-T | Familial focal epilepsy with variable foci | Uncertain significance (Oct 07, 2023) | ||
22-31754941-A-G | Familial focal epilepsy with variable foci • Inborn genetic diseases | Uncertain significance (Aug 27, 2023) | ||
22-31754942-C-G | Epilepsy, familial focal, with variable foci 1 • Familial focal epilepsy with variable foci • Inborn genetic diseases | Pathogenic (May 17, 2024) | ||
22-31754949-G-A | Familial focal epilepsy with variable foci | Uncertain significance (Jul 17, 2023) | ||
22-31754963-G-A | Familial focal epilepsy with variable foci | Likely benign (Apr 17, 2023) | ||
22-31754966-C-T | Familial focal epilepsy with variable foci • Inborn genetic diseases | Likely benign (Nov 18, 2023) | ||
22-31754971-G-T | Uncertain significance (Mar 28, 2022) | |||
22-31754977-G-C | Epilepsy, familial focal, with variable foci 1 | not provided (-) | ||
22-31754980-G-A | Familial focal epilepsy with variable foci | Likely pathogenic (Oct 01, 2022) | ||
22-31754981-T-C | Familial focal epilepsy with variable foci | Likely pathogenic (Dec 11, 2023) | ||
22-31754984-G-C | Likely pathogenic (Apr 29, 2016) | |||
22-31754985-T-C | Familial focal epilepsy with variable foci | Uncertain significance (Feb 03, 2020) | ||
22-31754988-C-T | Familial focal epilepsy with variable foci | Likely benign (Jan 22, 2024) | ||
22-31754989-G-A | Familial focal epilepsy with variable foci | Likely benign (Sep 20, 2023) | ||
22-31754989-G-C | Familial focal epilepsy with variable foci | Likely benign (Dec 30, 2022) | ||
22-31754989-G-T | Familial focal epilepsy with variable foci | Likely benign (Jun 01, 2022) | ||
22-31754994-G-A | Familial focal epilepsy with variable foci | Likely benign (Oct 03, 2023) | ||
22-31754996-C-T | Familial focal epilepsy with variable foci | Likely benign (Jul 30, 2021) | ||
22-31755127-A-G | Likely benign (Jul 26, 2018) | |||
22-31755156-A-G | Likely benign (Jul 31, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
DEPDC5 | protein_coding | protein_coding | ENST00000382112 | 42 | 153069 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.117 | 0.883 | 124867 | 0 | 43 | 124910 | 0.000172 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.65 | 713 | 942 | 0.757 | 0.0000568 | 10514 |
Missense in Polyphen | 258 | 395.16 | 0.65289 | 4348 | ||
Synonymous | 0.835 | 338 | 358 | 0.944 | 0.0000225 | 3024 |
Loss of Function | 7.15 | 24 | 102 | 0.235 | 0.00000600 | 1045 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000595 | 0.000529 |
Ashkenazi Jewish | 0.0000993 | 0.0000993 |
East Asian | 0.000285 | 0.000277 |
Finnish | 0.000279 | 0.000278 |
European (Non-Finnish) | 0.000125 | 0.000123 |
Middle Eastern | 0.000285 | 0.000277 |
South Asian | 0.000164 | 0.000163 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: As a component of the GATOR1 complex functions as an inhibitor of the amino acid-sensing branch of the TORC1 pathway. The GATOR1 complex strongly increases GTP hydrolysis by RRAGA and RRAGB within RRAGC-containing heterodimers, thereby deactivating RRAGs, releasing mTORC1 from lysosomal surface and inhibiting mTORC1 signaling. The GATOR1 complex is negatively regulated by GATOR2 the other GATOR subcomplex in this amino acid-sensing branch of the TORC1 pathway. {ECO:0000269|PubMed:23723238, ECO:0000269|PubMed:25457612, ECO:0000269|PubMed:29769719}.;
- Disease
- DISEASE: Epilepsy, familial focal, with variable foci 1 (FFEVF1) [MIM:604364]: An autosomal dominant form of epilepsy characterized by focal seizures arising from different cortical regions in different family members. Many patients have an aura and show automatisms during the seizures, whereas others may have nocturnal seizures. There is often secondary generalization. Some patients show abnormal interictal EEG, and some patients may have intellectual disability or autism spectrum disorders. Seizure onset usually occurs in the first or second decades, although later onset has been reported, and there is phenotypic variability within families. Penetrance of the disorder is incomplete. {ECO:0000269|PubMed:23542697, ECO:0000269|PubMed:23542701, ECO:0000269|PubMed:24283814, ECO:0000269|PubMed:24591017, ECO:0000269|PubMed:25366275, ECO:0000269|PubMed:26505888, ECO:0000269|PubMed:27173016}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Inactivating mutations and truncating deletions in the genes encoding GATOR1 proteins, including DEPDC5, are detected in glioblastoma and ovarian tumors and are associated with loss of heterozygosity events. Inactivation of GATOR1 proteins promotes constitutive localization of mTORC1 to the lysosomal membrane and blocks mTORC1 inactivation following amino acid withdrawal (PubMed:23723238). {ECO:0000269|PubMed:23723238}.;
- Pathway
- mTOR signaling pathway - Homo sapiens (human)
(Consensus)
Recessive Scores
- pRec
- 0.0928
Intolerance Scores
- loftool
- 0.494
- rvis_EVS
- -1.12
- rvis_percentile_EVS
- 6.62
Haploinsufficiency Scores
- pHI
- 0.194
- hipred
- Y
- hipred_score
- 0.597
- ghis
- 0.544
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.479
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Depdc5
- Phenotype
- skeleton phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); homeostasis/metabolism phenotype; growth/size/body region phenotype;
Zebrafish Information Network
- Gene name
- depdc5
- Affected structure
- whole organism
- Phenotype tag
- abnormal
- Phenotype quality
- increased behavioural activity
Gene ontology
- Biological process
- negative regulation of TOR signaling;cellular response to amino acid starvation;intracellular signal transduction;positive regulation of GTPase activity;negative regulation of TORC1 signaling
- Cellular component
- lysosome;lysosomal membrane;cytosol;Cul3-RING ubiquitin ligase complex;perinuclear region of cytoplasm;GATOR1 complex
- Molecular function
- GTPase activator activity;protein-containing complex binding